270 related articles for article (PubMed ID: 6188490)
41. Production of the modified form of human plasminogen by alpha 2-macroglobulin-plasmin complexes.
Yamamoto J; Okamoto U; Morita S; Asada N; Yamaoka M
Jpn J Physiol; 1985; 35(6):1013-21. PubMed ID: 2422420
[TBL] [Abstract][Full Text] [Related]
42. Effect of exercise on F VIII-complex: proportional increase of ristocetin cofactor (Von Willebrand factor) and F VIII-AGN, but disproportional increase of F VIII-AHF.
Stibbe J
Thromb Res; 1977 Jan; 10(1):163-8. PubMed ID: 300513
[No Abstract] [Full Text] [Related]
43. Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin.
Gonias SL; Einarsson M; Pizzo SV
J Clin Invest; 1982 Aug; 70(2):412-23. PubMed ID: 6178757
[TBL] [Abstract][Full Text] [Related]
44. Analysis of thiolester bond cleavage-dependent conformational changes in binary alpha 2-macroglobulin-proteinase complexes.
Roche PA; Pizzo SV
Arch Biochem Biophys; 1988 Nov; 267(1):285-93. PubMed ID: 2461679
[TBL] [Abstract][Full Text] [Related]
45. Isolation, subunit structure, and proteolytic modification of bovine factor VIII.
Legaz ME; Weinstein MJ; Heldebrant CM; Davie EW
Ann N Y Acad Sci; 1975 Jan; 240():43-61. PubMed ID: 122888
[TBL] [Abstract][Full Text] [Related]
46. Thrombin-activated and factor Xa-activated human factor VIII: differences in cofactor activity and decay rate.
Neuenschwander PF; Jesty J
Arch Biochem Biophys; 1992 Aug; 296(2):426-34. PubMed ID: 1632634
[TBL] [Abstract][Full Text] [Related]
47. Factor VIII: structure and function in blood clotting.
Chavin SI
Am J Hematol; 1984 Apr; 16(3):297-306. PubMed ID: 6424437
[TBL] [Abstract][Full Text] [Related]
48. Dissociation of the Factor-VIII complex during clotting: role of thrombin and phospholipids.
Muntean W; Rothwangl HJ
Eur J Clin Invest; 1984 Dec; 14(6):462-8. PubMed ID: 6441724
[TBL] [Abstract][Full Text] [Related]
49. Identification of a monoclonal antibody specific for a neoantigenic determinant on alpha 2-macroglobulin: use for the purification and characterization of binary proteinase-inhibitor complexes.
Strickland DK; Steiner JP; Migliorini M; Battey FD
Biochemistry; 1988 Mar; 27(5):1458-66. PubMed ID: 2452653
[TBL] [Abstract][Full Text] [Related]
50. Mechanism of alpha 2-macroglobulin-proteinase interactions. Studies with trypsin and plasmin.
Christensen U; Sottrup-Jensen L
Biochemistry; 1984 Dec; 23(26):6619-26. PubMed ID: 6085009
[TBL] [Abstract][Full Text] [Related]
51. Interaction of alpha 2-macroglobulin with trypsin, chymotrypsin, plasmin, and papain.
Howell JB; Beck T; Bates B; Hunter MJ
Arch Biochem Biophys; 1983 Feb; 221(1):261-70. PubMed ID: 6187288
[TBL] [Abstract][Full Text] [Related]
52. Adsorption of von Willebrand factor/factor VIII by the genetically distinct interstitial collagens.
Santoro SA
Thromb Res; 1981 Mar; 21(6):689-91. PubMed ID: 6791300
[No Abstract] [Full Text] [Related]
53. Hydrolysis of human platelet membrane glycoproteins with a Serratia marcescens metalloprotease: effect on response to thrombin and von Willebrand factor.
Cooper HA; Bennett WP; White GC; Wagner RH
Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1433-7. PubMed ID: 7041120
[TBL] [Abstract][Full Text] [Related]
54. Preferential binding of high molecular weight forms of von Willebrand factor to fibrillar collagen.
Santoro SA
Biochim Biophys Acta; 1983 Mar; 756(1):123-6. PubMed ID: 6402037
[TBL] [Abstract][Full Text] [Related]
55. Altered serum factor VIII-related antigen (VIII : AGN)/von Willebrand factor (VIII : vWf) in haemophiliacs with inhibitors to factor VIII procoagulant activity (VIII : C).
Ballard JO; Sanders JC; Eyster ME
Thromb Haemost; 1981 Feb; 45(1):68-72. PubMed ID: 6166064
[TBL] [Abstract][Full Text] [Related]
56. Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V.
Fulcher CA; Gardiner JE; Griffin JH; Zimmerman TS
Blood; 1984 Feb; 63(2):486-9. PubMed ID: 6419799
[TBL] [Abstract][Full Text] [Related]
57. Some consequences of the covalent and non-covalent binding modes of plasmin with alpha 2-macroglobulin.
Pochon F
Biochim Biophys Acta; 1987 Sep; 915(1):37-45. PubMed ID: 2441753
[TBL] [Abstract][Full Text] [Related]
58. Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.
Gralnick HR
J Clin Invest; 1978 Aug; 62(2):496-9. PubMed ID: 307560
[TBL] [Abstract][Full Text] [Related]
59. Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration.
Lombardi R; Mannucci PM; Seghatchian MJ; Garcia VV; Coppola R
Br J Haematol; 1981 Sep; 49(1):61-8. PubMed ID: 6791681
[TBL] [Abstract][Full Text] [Related]
60. Support of ristocetin-induced platelet aggregation by procoagulant-inactive and plasmin-cleaved forms of human factor VIII/von Willebrand factor.
Andersen JC; Switzer ME; McKee PA
Blood; 1980 Jan; 55(1):101-8. PubMed ID: 6444272
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
